Aquestive Therapeutics Inc.
Organization details
- Legal name
- Aquestive Therapeutics Inc.
- Former names
- MonoSol Rx, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Warren
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- AQST
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001398733
- EIN
- 20-8623253
Board of directors
-
Abigail L. Jenkins · DirectorSince 2024
-
Daniel Barber · Director · President and CEOSince 2025
-
Gregory B. Brown · DirectorSince 2023
-
John Cochran · DirectorSince 2023
-
Julie Krop · DirectorSince 2023
-
Marco Taglietti · DirectorSince 2023
-
Richard J. Daly · DirectorSince 2026
-
Santo J. Costa · DirectorSince 2023
-
Timothy E. Morris · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
-
100.0%
Board connections
3 of this board's directors also sit on 3 other boards. 3 are in the same sector.
-
Cytokinetics Incorporated Same sectorvia Santo J. Costa
-
DBV Technologies S.A. Same sectorvia Timothy E. Morris
-
Lisata Therapeutics Inc. Same sectorvia Gregory B. Brown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,394,114
- 16 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 21, 2026 | John Cochran Director | Other | +62,229 | — | — |
| Oct 15, 2026 | Daniel Barber Director, Officer (President and CEO) | Open-market sale | −25,000 | $4.22 | $105,600 |
| Sep 15, 2026 | Daniel Barber Director, Officer (President and CEO) | Open-market sale | −25,000 | $4.82 | $120,500 |
| Sep 9, 2026 | Boyd Peter E. Officer (Chief People Officer) | In-the-money exercise | +2,293 | $0.96 | $2,201 |
| Sep 9, 2026 | Korczynski Sherry Officer (Chief Commercial Officer) | Option exercise | +8,750 | $2.65 | $23,188 |
| Sep 9, 2026 | Korczynski Sherry Officer (Chief Commercial Officer) | Open-market sale | −8,750 | $5.22 | $45,675 |
| Sep 8, 2026 | Daniel Barber Director, Officer (President and CEO) | In-the-money exercise | +91,743 | $0.96 | $88,073 |
| Sep 3, 2026 | Jung Cassie Officer (Chief Operating Officer) | In-the-money exercise | +4,587 | $0.96 | $4,404 |
| Aug 17, 2026 | Daniel Barber Director, Officer (President and CEO) | Open-market sale | −25,000 | $4.29 | $107,250 |
| Aug 14, 2026 | Korczynski Sherry Officer (Chief Commercial Officer) | Shares withheld for tax | −2,714 | $4.25 | $11,535 |
| Jul 16, 2026 | Daniel Barber Officer (President and CEO) | Open-market sale | −20,369 | $4.00 | $81,476 |
| Jul 15, 2026 | Daniel Barber Officer (President and CEO) | Open-market sale | −4,631 | $4.03 | $18,663 |
| Jun 23, 2026 | Julie Krop Director | Option exercise | +25,000 | $0.71 | $17,750 |
| Jun 23, 2026 | Julie Krop Director | Open-market sale | −25,000 | $5.02 | $125,500 |
| Jun 15, 2026 | Daniel Barber Officer (President and CEO) | Open-market sale | −25,000 | $4.16 | $104,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Aquestive Therapeutics Inc.
Who is the CEO of Aquestive Therapeutics Inc.?
Daniel Barber is Aquestive Therapeutics Inc.'s President and CEO.
How many directors are on Aquestive Therapeutics Inc.'s board?
Aquestive Therapeutics Inc.'s board has 9 directors: Abigail L. Jenkins, Daniel Barber, Gregory B. Brown, John Cochran, Julie Krop, Marco Taglietti, Richard J. Daly, Santo J. Costa and Timothy E. Morris.
Are Aquestive Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Aquestive Therapeutics Inc. insiders made no open-market purchases and sold $2.4 million of shares in 16 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="aquestive-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.